Research Press Releases Advancement
The University of Colorado Anschutz Medical Campus today announced the creation of the Gates Institute, a state-of-the-art facility that will focus on rapidly translating laboratory findings into regenerative, cellular and gene therapies for patients.
The family of actor Bruce Willis recently announced that he would be stepping away from acting following an aphasia diagnosis – a language disorder caused by damage to the areas of the brain responsible for expression and comprehension.
Robin Gabriels, PsyD, MA, is studying how equine therapy in youth with autism has led to a decrease in their symptoms while boosting verbal and social skills. The outcomes last at least six months after the therapeutic riding ends. Now she wants to understand the physiology behind it all.
Awareness Neuroscience CU Anschutz 360 Podcast
Kelsea Pieters | 
May 02, 2022
Moksha Patel, MD, is a busy man. He recently finished a fellowship in the Division of Hospital Medicine at the University of Colorado School of Medicine where he is now a senior instructor. He’s been appointed lead physician informaticist for the Institute for Healthcare Quality, Safety, and Efficiency at CU Anschutz and is working toward an MBA at CU Denver.
The University of Colorado Anschutz Medical Campus has announced that it will make a $200 million investment over the next five years to create the Gates Institute, a research and treatment center that will focus on the development of new regenerative, cellular and gene therapies for a variety of serious illnesses.
We spoke with Kevin Messacar, MD, PhD, a pediatric infectious disease physician and researcher at Children's Hospital Colorado and the University of Colorado School of Medicine, about the cases and other uncommon pediatric illnesses caused by infections, including acute flaccid myelitis (AFM).
Other public health experts worry Colorado and the U.S. may be flying blind. Many governments dropped non-pharmaceutical interventions like masking and contact tracing, while not beefing up surveillance enough to give warning of a potential coming surge, said May Chu, an epidemiologist and clinical professor, also at the Colorado School of Public Health.
Dr. Kristine Erlandson, an associate professor of medicine and infectious disease specialist at the University of Colorado [School of Medicine], has been doing her part by recruiting participants for a study of the long-term impact of Covid-19. The initiative is a part of the National Institutes of Health's RECOVER trial.
CU Anschutz Newsroom